Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -189.47%-169.07M | |||||||||
Net income from continuing operations | ---- | ---- | ---- | ---- | ---- | 18.77%-2.18B | ---- | ---- | ---- | ---- |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | -79.61%74.09M | ---- | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -18.74%940.48M | ---- | ---- | ---- | ---- |
Deferred tax | ---- | ---- | ---- | ---- | ---- | 30.42%-24.49M | ---- | ---- | ---- | ---- |
Other non cash items | ---- | ---- | ---- | ---- | ---- | -59.14%57.05M | ---- | ---- | ---- | ---- |
Change In working capital | ---- | ---- | ---- | ---- | ---- | -175.44%-394.42M | ---- | ---- | ---- | ---- |
-Change in receivables | ---- | ---- | ---- | ---- | ---- | -54.03%362.24M | ---- | ---- | ---- | ---- |
-Change in prepaid assets | ---- | ---- | ---- | ---- | ---- | -263.08%-216.3M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | ---- | ---- | -42.02%-502.95M | ---- | ---- | ---- | ---- |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | 14.42%-37.4M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 471.69%628.42M | 3,311.44%570.22M | 1,020.97%228.36M | 131.75%151.17M | -18.41%-321.34M | -189.47%-169.07M | 106.54%16.72M | -79.82%20.37M | -81.02%65.23M | 56.65%-271.39M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,948.34%-673.19M | |||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | -40.64%-1.95B | ---- | ---- | ---- | ---- |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | 68.15%-5.98M | ---- | ---- | ---- | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | 96.37%-8.12M | ---- | ---- | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | -14.11%1.28B | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | -95.61%4.37M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -437.81%-3.62B | 5.43%-1.34B | -377.80%-458.62M | -354.98%-654.83M | -465.69%-1.17B | -1,948.34%-673.19M | -476.08%-1.41B | -49.01%165.09M | 135.05%256.82M | 160.92%319.67M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 80.22%-227.85M | |||||||||
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | 149.88%446.11M | ---- | ---- | ---- | ---- |
Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | 114.69%3.85M | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | -2,822.22%-677.81M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,528.74%3.26B | 56.11%1.8B | 85.49%-183.39M | 335.20%523.95M | 969.38%1.11B | 80.22%-227.85M | 262.87%1.15B | -867.06%-1.26B | 28.69%-222.77M | 6.54%103.99M |
Net cash flow | ||||||||||
Beginning cash position | -29.55%2.49B | -37.39%1.71B | -45.16%2.1B | -42.97%2.09B | -29.55%2.49B | -20.71%3.53B | -14.81%2.73B | 37.68%3.82B | 8.39%3.67B | -20.71%3.53B |
Current changes in cash | 124.61%263.39M | 525.52%1.04B | 61.64%-413.65M | -79.56%20.29M | -348.40%-378.26M | -7.44%-1.07B | 58.66%-243.23M | -466.83%-1.08B | 114.15%99.28M | 114.46%152.28M |
Effect of exchange rate changes | -188.05%-22.77M | -1,510.89%-15.29M | 312.13%27.63M | -125.42%-14.65M | -3.26%-20.46M | -64.64%25.86M | 100.68%1.08M | -109.61%-13.03M | -39.93%57.62M | 5.70%-19.82M |
End cash Position | 9.67%2.73B | 9.67%2.73B | -37.39%1.71B | -45.16%2.1B | -42.97%2.09B | -29.55%2.49B | -29.55%2.49B | -14.81%2.73B | 37.68%3.82B | 8.39%3.67B |
Free cash flow | 129.45%628.42M | 129.27%570.22M | 1,020.97%228.36M | 131.75%151.17M | -18.41%-321.34M | -70.92%-2.13B | -15.07%-1.95B | -79.82%20.37M | -81.02%65.23M | 56.65%-271.39M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |